Piramal Pharma’s Rs 1,050-cr rights issue gets Sebi’s nod
Going by the draft papers, Piramal Pharma will issue fully paid-up equity shares of the company by way of a rights issue to its existing eligible shareholders for an amount aggregating up to Rs 1,050 crore.
